Host: Michael Benson, MD

Guest: Scott Gottlieb, MD

How much did regular use of Vioxx for long periods of time increase the risk of heart attack? What is the risk of suicide with the SSRI’s in select patient populations? The answers can only come through a robust system for monitoring post-marketing drug safety. Yet the new regulations being considered by the FDA and Congress may not be a prescription for improved safety.